• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    NUBURU Announces Strategic Corporate Update Focused on Defense & Security, Advanced Technologies, and Growth Initiatives

    4/15/25 8:33:00 AM ET
    $BURU
    $COEP
    Industrial Machinery/Components
    Miscellaneous
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $BURU alert in real time by email

    Shareholder Update: Strengthening Business Lines Through Innovative Applications in Blue Laser Technology, Artificial Intelligence, Robotics, and Fintech Solutions

    NUBURU, Inc. (NYSE:BURU), a leader in high-power and high-brightness industrial blue laser technology, is excited to provide a comprehensive update to its shareholders regarding its newly formulated business model canvas, which encompasses two synergistic key business lines.

    Blue Laser Technology & Product Development.

    NUBURU is revitalizing its blue-laser technology business unit by collaborating closely with the previous management team to develop a new strategic plan aimed specifically at addressing the defense sector's needs and other few synergistic vertical applications. The recent Joint-Pursuit Agreement signifies the company's commitment to leveraging its innovative laser solutions for defense applications. This enhanced focus will also explore vertical applications of the technology, pursuing both new intellectual property (IP) rights and the strategic use of licensed IP rights.

    Defense & Security Hub Acquisition.

    As part of its acquisition plan, NUBURU is on track to finalize the purchase of Defense & Security companies, referred to herein as the "Defense & Security Hub" for confidential reasons. This hub will concentrate on delivering cutting-edge products tailored for defense applications while extending its robust security solutions through a software-as-a-service (SaaS) model, effectively catering to sectors where operational resilience is a regulatory requirement. These acquisitions are projected to contribute approximately over $50 million in 2025 revenue to NUBURU, subject to U.S. GAAP accounting and contingent upon regulatory and shareholder approvals and timing of the acquisitions.

    Investment & Partnerships in Advanced Technologies and Innovations.

    NUBURU remains committed to navigating its Transformation Plan, which emphasizes the adoption of exponential technologies, including AI and robotics, and innovative solutions which can underpin the Company' two key business lines. As a part of this plan entering into the fastest growing global industry of Artificial Intelligence, NUBURU formed a strategic partnership with COEPTIS' NexGenAI Affiliates Network (NASDAQ:COEP), an innovative provider of artificial intelligence and robotics solutions. NextGen's advanced platform utilizes sophisticated AI algorithms and data analytics to optimize marketing strategies, enhance customer engagement, and implement operational efficiencies. This allows NUBURU a broader goal of fostering an ecosystem where technology serves as a catalyst for growth and innovation.

    Furthermore, as NUBURU has previously announced it has made a significant strategic investment in Supply@ME Capital Plc (LON:SYME) ("SYME"), a disruptive fintech platform focused on Inventory Monetisation© solutions for manufacturing and trading companies. This allows NUBURU to continue to strengthen its operational framework to support working capital needs over its two key business lines, particularly in inventory management, as global trade dynamics and regional supply chains evolve. Also, the clients of SYME' Platform can enable cross-selling strategies with the Defense & Security Hub, in particular the SaaS solutions which Nuburu will be able to offer, following the acquisitions.

    Strategic Financial Management & Elimination of previous debts.

    As a part of this transformation, NUBURU is focused on addressing legacy issues, including the settlement of outstanding payables from previous management and enhancing its position with preferred stockholders. As a part of this tremendous transformation plan NUBURU previously announced the elimination of 100% of long-term indebtedness allowing financial flexibility for future transactions and is in the process on finalizing its final payables with a strategic funding partner.

    "We are excited to share these strategic updates with our shareholders and underscore our focus on creating significant value through our dual business lines," said Alessandro Zamboni, Executive Chairman of NUBURU. "By advancing our blue-laser technology and expanding our presence in the defense and security sector through innovative solutions, we aim to solidify NUBURU's position as a leader in high-growth, high-demand markets."

    About NUBURU

    NUBURU, Inc. was founded in 2015 as a developer and manufacturer of industrial blue laser technology that is transforming the speed and quality of laser-based manufacturing. Under its new management team led by Executive Chairman Alessandro Zamboni, NUBURU is executing a comprehensive growth and diversification strategy, expanding into complementary domains such as defense-tech, security, and operational resilience solutions. Headquartered in Centennial, Colorado, NUBURU is leveraging strategic partnerships and acquisitions to accelerate growth in high-value sectors. For more information, visit www.nuburu.net.

    Forward-Looking Statements

    This press release contains certain "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this press release may be forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe," "predict," "plan," "seek," "targets," "projects," "could," "would," "continue," "forecast" or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts, and assumptions that, while considered reasonable by the Company and its management, are inherently uncertain. Many factors may cause the Company's actual results to differ materially from current expectations, including but are not limited to: (1) the ability to meet security exchange listing standards; (2) the impact of the loss of the Company's patent portfolio through the previously announced foreclosure; (3) failure to achieve expectations regarding business development and the Company's acquisition strategy; (4) the inability to access sufficient capital to operate; (5) the inability to recognize the anticipated benefits of the initial business combination and the current transaction, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (6) changes in applicable laws or regulations; (7) adverse impacts of general economic, business, and competitive factors; (8) volatility in the financial system and markets caused by geopolitical and economic factors; and (9) other risks and uncertainties set forth in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's most recent periodic report on Form 10-K or Form 10-Q and other documents filed with the SEC from time to time. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company does not give any assurance that it will achieve its expected results. The Company assumes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by applicable law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250415617014/en/

    NUBURU, Inc. (NYSE:BURU)

    Investor Relations: [email protected]

    Media Contact: [email protected]

    Website: www.nuburu.net

    Get the next $BURU alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BURU
    $COEP

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $BURU
    $COEP
    Financials

    Live finance-specific insights

    See more
    • NUBURU Takes Strategic Leap Forward: First Acquisition Step in Defense and Security Sector Completed

      Initial 20% Acquisition Completed, Creating New Foundation to Deploy Laser Technology Applications NUBURU, Inc. (NYSE:BURU), a leader in high-power and high-brightness industrial blue laser technology, is proud to announce the successful completion of the first key step in its strategic acquisition plan focused on the defense and security business sector. This pivotal move aligns with the Company's ongoing commitment to cultivate synergies with its existing laser technology expertise and the adoption of cutting-edge, AI-driven solutions and robotic process automation capabilities by virtue of the recent partnership with NexGenAI. Following the announcement of entering into a commitment le

      3/12/25 8:30:00 AM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • HUMBL, Inc. Announces $2 Million Share Exchange Agreement and Strategic Partnership With NUBURU, Inc. to Accelerate Growth and Shareholder Value

      San Diego, CA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC:HMBL) announced the execution of a $2,000,000 Equity Swap Agreement and strategic partnership with NUBURU, Inc. (NYSE:BURU) designed to accelerate both companies' growth strategies and deliver immediate value to shareholders. Transaction Details Under the terms of the Equity Swap Agreement: NUBURU will issue $2,000,000 in common stock to HUMBL (subject to applicable exchange cap, stockholder approval, and registration requirements); andHUMBL will issue an equal dollar amount of Series C Preferred Stock to NUBURU. Following satisfaction of any required stockholder or regulatory approvals and registration requirements, it

      2/28/25 6:00:00 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • NUBURU, Inc. and HUMBL, Inc. Announce $2 Million Share Exchange Agreement and Strategic Partnership to Accelerate Growth and Shareholder Value

      NUBURU, Inc. (NYSE:BURU, the "Company")), a leading innovator in high-power blue laser technology, and HUMBL, Inc. (OTC:HMBL), a strategic holding company with focus in Brazil, today announced the execution of a $2 million Equity Swap Agreement and strategic partnership designed to accelerate both companies' growth strategies and deliver immediate value to shareholders. Transaction Details Under the terms of the Equity Swap Agreement: NUBURU will issue $2 million in common stock to HUMBL (subject to applicable exchange cap, stockholder approval, and registration requirements); and HUMBL will issue an equal amount of Series C Preferred Stock to NUBURU Following satisfaction of a

      2/28/25 5:44:00 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous

    $BURU
    $COEP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NUBURU Reveals TEKNE as Targeted Acquisition in the Advanced Defense Technologies

      The Acquisition, subject to regulatory and stockholders approval, will Enhance Revenue Streams to $50 Million as NUBURU Revitalizes Blue Laser Technology to be integrated within the new State-of-the Art Defense & Security Hub NUBURU, Inc. (NYSE:BURU), a front-runner in high-power blue laser technology, reveals Tekne S.p.A. ("TEKNE") as targeted acquisition, a distinguished provider of integrated electronic warfare and cyber capabilities within military vehicles. As previously announced, NUBURU awaits approval from the Italian government under the "golden power" regulations, which oversee foreign investments in critical sectors aligned with national security interests. Also, the completion

      5/22/25 8:35:00 AM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • NUBURU Reveals Its Strategic Trajectory in the Defense Sector

      While NUBURU awaits the Italian government's golden power, it outlines its defense go-to-market strategy and technological advancements NUBURU, Inc. (NYSE:BURU), a leader in high-power blue laser technology, is proud to announce the official kick off of the working group made by the mutual management teams of BURU' and the targeted defense-tech company ("DefenseTech Business") part of the acquisition plan. The working group will also oversight the research and the development of advanced laser-tech-based solutions designed specifically for defense applications, as part of the Company' strategic expansion in the defense sector, under the joint-pursuit agreement signed in March. This announ

      5/20/25 8:56:00 AM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • NUBURU Files $100M SEC Registration Statement to Enhance Capital Flexibility for Completion of Defense Acquisition and Blue Laser Technology Revitalization Targeting a $500B Defense Market

      NUBURU Poised to Finalize Strategic Acquisition and Prepare the Adoption of Advanced Technology, Artificial Intelligence & Robotics Initiatives as It Awaits Italian Government ‘Golden Power' Approval NUBURU, Inc. (NYSE:BURU), a leader in high-power blue laser technology, announced today that it has filed with the Securities and Exchange Commission a Form S-3 Registration statement for $100 million. This strategic move is designed to provide the company with the necessary capital to facilitate the ongoing acquisition plan and successfully relaunch its Blue Laser technology business unit. As reaffirmed in the latest communications, NUBURU aims at completing the purchase of defense and secur

      5/12/25 8:20:00 AM ET
      $BURU
      $COEP
      Industrial Machinery/Components
      Miscellaneous
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $BURU
    $COEP
    SEC Filings

    See more
    • SEC Form 10-Q filed by Nuburu Inc.

      10-Q - Nuburu, Inc. (0001814215) (Filer)

      5/20/25 5:28:45 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form NT 10-Q filed by Nuburu Inc.

      NT 10-Q - Nuburu, Inc. (0001814215) (Filer)

      5/16/25 5:10:03 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • Nuburu Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - Nuburu, Inc. (0001814215) (Filer)

      5/16/25 5:10:09 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous

    $BURU
    $COEP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Nuburu Inc.

      SC 13D/A - Nuburu, Inc. (0001814215) (Subject)

      11/25/24 8:59:19 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • Amendment: SEC Form SC 13G/A filed by Coeptis Therapeutics Holdings Inc.

      SC 13G/A - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)

      11/14/24 3:59:49 PM ET
      $COEP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form SC 13G filed by Nuburu Inc.

      SC 13G - Nuburu, Inc. (0001814215) (Subject)

      8/12/24 8:59:36 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous

    $BURU
    $COEP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Deschamps Philippe

      4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)

      3/10/25 9:23:25 PM ET
      $COEP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Cogley Brian

      4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)

      3/6/25 5:29:47 PM ET
      $COEP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by VP of Operations Yerace Daniel Alexander

      4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)

      3/6/25 5:29:34 PM ET
      $COEP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $BURU
    $COEP
    Leadership Updates

    Live Leadership Updates

    See more
    • NUBURU, Inc. Receives Notice of Non-Compliance with the NYSE

      NUBURU, Inc. ("NUBURU" or the "Company") (NYSE:BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced it has received a notice of non-compliance (the "NYSE Notice") from the staff of the NYSE American Market (the "Exchange") indicating that the Company has become noncompliant with the continued listing standard set forth in Section 803B(2)(c) of the NYSE American Company Guide (the "Company Guide"), since the Company's Audit Committee is no longer comprised of at least two independent directors, as a result of the recent resignation of an independent director from the Company's Board of Directors. The NYSE Notice stated that, pursuant

      11/22/24 6:45:00 PM ET
      $BURU
      Industrial Machinery/Components
      Miscellaneous
    • NUBURU Appoints Brian Knaley as new CEO

      NUBURU, Inc. ("NUBURU" or the "Company") (NYSE:BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced the appointment of Brian Knaley as the Company's new Chief Executive Officer, replacing Dr. Mark Zediker, who has left the Company to pursue other opportunities. Mr. Knaley has also joined NUBURU's Board of Directors upon assuming the role. Mr. Knaley, who had served as the Company's Chief Financial Officer since February 2022, has over 25 years of experience in finance and operations. Prior to joining NUBURU, Mr. Knaley served as the chief financial officer of CEA Industries Inc. (NASDAQ:CEAD), a provider of controlled environmental

      11/1/23 4:30:00 PM ET
      $BURU
      $CEAD
      $VRAY
      Industrial Machinery/Components
      Miscellaneous
      Industrials
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
    • Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical Officer

      Dr. Delaney joins Coeptis after securing exclusive rights from Deverra Therapeutics for its allogeneic immuno-oncology platform and clinical stage programs WEXFORD, Pa., Aug. 30, 2023 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced that Colleen Delaney, MD, MSc, has been appointed Chief Scientific and Medical Officer of Coeptis following the completion of an exclusive rights agreement with Deverra Therapeutics for its allogeneic immuno-oncology platform and clinical stage programs.

      8/30/23 1:00:00 PM ET
      $COEP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care